Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSecure Trust Bank Regulatory News (STB)

Share Price Information for Secure Trust Bank (STB)

Share Price is delayed by 15 minutes
Get Live Data
1,254.00    -22.00 (-1.72%)
Bid:
1,258.00
Ask:
1,280.00
Spread: 22.00 (1.749%)
Market Cap: £234.93m
STB Live PriceLast checked at - London Stock Exchange

Intraday Secure Trust Bank Share Chart

Pre-Close Trading Update

14 Jan 2016 07:00

RNS Number : 8038L
Arbuthnot Banking Group PLC
14 January 2016
 

PRESS RELEASE

For Immediate release

 

14 January 2016

ARBUTHNOT BANKING GROUP PLC

PRE-CLOSE TRADING UPDATE

Arbuthnot Banking Group PLC ("Arbuthnot" or "the Group") today issues a pre-close trading update ahead of its preliminary results announcement for the year ended 31 December 2015 which is scheduled for 17 March 2016.

The Group continued to trade well in the fourth quarter and as a result expects to report a pre-tax profit in line with market expectations.

The sale of Everyday Loans is still expected to complete in the first quarter of 2016 and it is anticipated this will increase the regulatory capital base of the Group by 74%, before deducting the surplus minority interest.

Retail Banking

Secure Trust Bank PLC ("STB") saw strong overall growth in its lending portfolios, which resulted in the total loan book closing in excess of £1BN, a growth rate of over 70%. Its consumer lending was led by Retail Finance and Motor, with new volumes materially higher than the prior year. STB has continued to make progress in the development of its SME lending activities in 2015. The Bank has seen strong demand for Asset Finance, Invoice Finance and Real Estate Finance. New lending volumes are 65% higher than in 2014.

Conditions in the savings market remain favourable as the bank continues to see good inflows of deposits across its product offerings.

STB remains strongly capitalised and well-funded.

Private Banking

In the third quarter update on 15 October 2015 Arbuthnot Latham and Co., Ltd. ("AL") noted that it had established a strong pipeline of lending. As anticipated this lending was drawn down during the fourth quarter and as a result the customer lending balances have ended the year in line with market expectations.

The other lines of business in the Private Bank continue to make good progress while the Commercial Banking division remains on track with its developments.

During the fourth quarter, AL was in exclusive negotiations to purchase a second portfolio of residential mortgages. This process was nearing a successful conclusion when the Bank of International Settlements ("BIS") published its second consultative document on its proposed revision to the standardised approach for credit risk on 10 December 2015.

While it is unclear how those proposals will eventually be implemented, the management view was that the direction of travel indicated would result in the anticipated return on capital from the mortgage portfolio falling below the desired levels being targeted by the Bank. As a result AL withdrew its offer and the resultant one off transaction costs of approximately £450,000 will be recorded in December 2015. 

Once again the Group has made significant progress during 2015, finishing the year with customer lending in excess of £1.6BN, its highest ever level.

Note: STB is also making a pre-close statement today which should be read in conjunction with this statement.

-ENDS-

 

Enquiries:

Arbuthnot Banking Group

Sir Henry Angest, Chairman and Chief Executive

Andrew Salmon, Group Chief Operating Officer

James Cobb, Group Finance Director

David Marshall, Director of Communications

020 7012 2400

Canaccord Genuity Ltd (Nominated Advisor)

Sunil Duggal

020 7665 4500

Numis Securities Ltd (Broker)

Chris Wilkinson

Mark Lander

020 7260 1000

Bell Pottinger (Financial PR)

Ben Woodford

Zoë Pocock

020 3772 2566

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTUOABRNUAAAAR
Date   Source Headline
7th Jul 20253:51 pmRNSDirector/PDMR Shareholding
4th Jul 20251:59 pmRNSDirector/PDMR Shareholding
2nd Jul 20257:00 amRNSStrategic pivot to increase Group ROAE
1st Jul 20253:34 pmRNSTotal Voting Rights
17th Jun 20257:00 amRNSCEO Succession Plan
16th Jun 20253:00 pmRNSDirector/PDMR Shareholding
12th Jun 20257:30 amRNSNon-Executive Director Appointment
30th May 20254:02 pmRNSTotal Voting Rights
15th May 20254:58 pmRNSResult of 2025 AGM
15th May 20257:00 amRNSQ1 2025 Trading Update
25th Apr 20255:50 pmRNSDirector/PDMR Shareholding
24th Apr 202511:43 amRNSDirector/PDMR Shareholding
17th Apr 20258:30 amRNSDirector/PDMR Shareholding
8th Apr 20254:43 pmRNSDirector/PDMR Shareholding
4th Apr 202511:20 amRNSNotice of AGM
26th Mar 20253:01 pmRNSDirector/PDMR Shareholding
24th Mar 20254:48 pmRNSDirector/PDMR Shareholding
24th Mar 20254:47 pmRNSDirector/PDMR Shareholding
17th Mar 20252:48 pmRNSDirector/PDMR Shareholding
13th Mar 20253:56 pmRNSAnnual Financial Report
13th Mar 20257:00 amRNSFinal Results
11th Mar 20259:00 amRNSNotice of Retail Investor Webcast
14th Feb 20252:11 pmRNSHolding(s) in Company
7th Feb 202511:59 amRNSHolding(s) in Company
7th Feb 202511:38 amRNSHolding(s) in Company
3rd Feb 20251:34 pmRNSBlock listing Interim Review
16th Jan 202511:07 amRNSHolding(s) in Company
24th Dec 202411:18 amRNSHolding(s) in Company
23rd Dec 20242:36 pmRNSHolding(s) in Company
19th Dec 20244:28 pmRNSDirector Declaration
18th Dec 202411:44 amRNSHolding(s) in Company
13th Dec 20243:14 pmRNSAppointment of Remuneration Committee Chairman
6th Dec 20245:07 pmRNSHolding(s) in Company
2nd Dec 20241:47 pmRNSDirector/PDMR Shareholding
19th Nov 20244:19 pmRNSHolding(s) in Company
13th Nov 20244:50 pmRNSDirector/PDMR Shareholding
13th Nov 20247:00 amRNSCapital Markets Event
8th Nov 20241:15 pmRNSHolding(s) in Company
1st Nov 20243:51 pmRNSHolding(s) in Company
1st Nov 20243:15 pmRNSDirector/PDMR Shareholding
1st Nov 20247:00 amRNSTrading Update
28th Oct 202412:14 pmRNSVehicle Finance Update
24th Oct 20247:30 amRNSNon-Executive Director Succession
16th Oct 20248:54 amRNSNotice of Capital Markets Event and Q3 Update
10th Oct 20244:37 pmRNSHolding(s) in Company
27th Sep 20243:37 pmRNSDirector/PDMR Shareholding
16th Sep 202411:31 amRNSDirector/PDMR Shareholding
2nd Sep 20248:30 amRNSTotal Voting Rights
21st Aug 20242:01 pmRNSDirector/PDMR Shareholding
19th Aug 202410:29 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.